✦ LIBER ✦

An interim analysis of the response to treatment of chronic hepatitis C with interferon-alfa-2b and ribavirin in a VA population

✍ Scribed by Edelstein, Marc A.; Ly, David; Saab, Sammy; Weston, Shiobhan; Lunn, Adrian; Garrett, Ben; Han, Steven-Huy

Book ID: 123345039
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 167 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)81639-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetic analysis of p

Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C

✍ Jen, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

Interferon alfa-2b (IFN-A2B)/ribavirin c

Interferon alfa-2b (IFN-A2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C

✍ M.H. Sjogren; K. Holtzmuller; R.W. Sjogren 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Evaluation of retinopathy in patients wi

Evaluation of retinopathy in patients with hepatitis C on pegylated interferon alfa-2b and ribavirin: An interim analysis

✍ Sheinbaum, Alan J.; Winn, Julie M.; Esrason, Karl T. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Peginterferon alfa-2b plus ribavirin com

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

✍ Michael P Manns; John G McHutchison; Stuart C Gordon; Vinod K Rustgi; Mitchell S 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 110 KB

Cost-effectiveness of interferon alfa 2b

Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C

✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th

Comparison between combination therapy w

Comparison between combination therapy with peg-interferon alfa-2A plus ribavirin and peg-interferon alfa-2B plus ribavirin in the treatment of chronic hepatitis C

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB